ROS-triggerable dual nanocoated probiotics for inflammatory bowel disease treatment

Inflammatory bowel disease (IBD), an immune-mediated chronic gastrointestinal disease, is difficult to treat because its specific pathogenic mechanisms are currently unclear, and its recurrence rate is high. Probiotic therapies have been used to treat IBD; however, challenges, including poor digesti...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Guangze Sang, Sizhen Wang, Qiwei Tai, Yunchang Zhang, Xufang Wang, Baoling Yan, Weiwei Jiang, Zhendong Chen, Linhong Sun, Jiao Zhou, Xiaoxian Wu, Zi Ye, Feng Yang, Jun Luo, Beibei Guo
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2026-12-01
Serija:	Drug Delivery
Teme:	Inflammatory bowel disease ulcerative colitis probiotics catechin Escherichia coli Nissle 1917
Online dostop:	https://www.tandfonline.com/doi/10.1080/10717544.2026.2630460
Oznake:	Označite Brez oznak, prvi označite!